498 results on '"Hachulla E"'
Search Results
2. Étude HYPNOSTRESS : intérêt de l’hypnose médicale dans l’évaluation du stress ressenti et le vécu d’une hospitalisation dans un service de médecine interne
3. Pulmonary hypertension in connective tissue diseases: What every CTD specialist should know – but is afraid to ask!
4. French National Diagnostic and Care Protocol for antiphospholipid syndrome in adults and children
5. Atteintes coronariennes et artérite a cellules géantes : à propos de 2 cas et revue de la littérature
6. Sindrome di Gougerot-Sjögren
7. French national diagnostic and care protocol for Sjögren's syndrome
8. Téloméropathies de recrutement hématologique : étude de 15 cas
9. Impact de l’angiœdème héréditaire sur les activités de la vie quotidienne, la sphère émotionnelle et la qualité de vie des patients
10. Exploration des dimensions de la personne lupique pour un environnement motivationnel en éducation thérapeutique du patient
11. French expert opinion for the management of juvenile dermatomyositis
12. Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behcet's disease: A multicenter observational study of 18 patients
13. Exclusion of Patients with a Severe T-Cell Defect Improves the Definition of Common Variable Immunodeficiency
14. Manifestations neurologiques centrales du syndrome des anticorps antiphospholipides
15. Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review, and meta-analysis of the literature
16. Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double‐Blind, Placebo‐Controlled Trials
17. Neurolupus (1re partie). Description et démarche diagnostique et thérapeutique dans les manifestations neurologiques centrales et psychiatriques au cours du lupus érythémateux systémique
18. Neurolupus (2e partie). Description des outils diagnostiques et thérapeutiques devant une manifestation psychiatrique ou neurologique centrale au cours du lupus érythémateux systémique
19. Hypertension artérielle pulmonaire associée aux connectivites : particularités cliniques et pronostiques
20. Quoi de neuf en médecine interne: traitements émergeants du lupus érythémateux systémique
21. Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögrenʼs Syndrome
22. Long-Term Outcomes Among Participants in the WEGENT Trial of Remission-Maintenance Therapy for Granulomatosis With Polyangiitis (Wegenerʼs) or Microscopic Polyangiitis
23. Takayasu Arteritis and Pregnancy
24. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients
25. Sclerodermia sistemica
26. Vaccination in adults with auto-immune disease and/or drug related immune deficiency: Results of the GEVACCIM Delphi survey
27. Myélopathies aiguës associées aux maladies systémiques
28. IMMUNOSUPPRESSION WITH TARGETED DMARDS REDUCES MORBIDITY AND MORTALITY IN PRE-CAPILLARY PULMONARY HYPERTENSION ASSOCIATED WITH SYSTEMIC SCLEROSIS: A EUSTAR ANALYSIS.
29. O.98 - Évaluation de l’efficacité des biothérapies dans le syndrome de Blau : étude sur une cohorte internationale de 23 cas
30. O.44 - Risque de complications systémiques au cours du syndrome de Sjögren primitif et rôle prédictif de la numération sanguine, de l’EPP, du dosage du complément, et de la recherche d’une cryoglobulinémie : données de la cohorte prospective de la SFR ASSESS
31. P.06 - Causes et facteurs prédictifs de mortalité dans la sclérodermie systémique : une analyse à partir de 3 700 décès
32. Vertebral fractures in Gaucher disease type I: data from the French “Observatoire” on Gaucher disease (FROG)
33. The neurological manifestations of Gaucher disease type 1: the French Observatoire on Gaucher disease (FROG)
34. STAT4 is a confirmed genetic risk factor for Sjögren's syndrome and could be involved in type 1 interferon pathway signaling
35. Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis
36. Cytokine concentrations in exhaled breath condensates in systemic sclerosis
37. Polymyosite et atteinte de nerfs crâniens
38. Complications maternelles graves des maladies systémiques auto-immunes
39. Molecular characterization of the idiopathic hypereosinophilic syndrome (HES) in 35 French patients with normal conventional cytogenetics
40. Long-term outcome in idiopathic granulomatous mastitis: a western multicentre study
41. Efficiency of immunoglobulin G replacement therapy in common variable immunodeficiency: correlations with clinical phenotype and polymorphism of the neonatal Fc receptor
42. Multidimensional analysis of clinical symptoms in patients with Fabry’s disease
43. Esclerodermia sistémica
44. Artériolopathie calcique (Calciphylaxie)
45. Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial
46. Fabry disease ‘The New Great Imposter’: results of the French Observatoire in Internal Medicine Departments (FIMeD)
47. Prevalence, characteristics and prognostic significance of anemia in daily practice
48. S.11.1 Influence of digital ulcer healing on disability and daily activity limitations in SSc
49. S.4.1 N-terminal pro-brain natriuretic peptide levels predict incident pulmonary arterial hypertension in SSc
50. Evidence of the Contribution of the X Chromosome to Systemic Sclerosis Susceptibility: Association With the Functional Irak1 196Phe/532Ser Haplotype
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.